The things To Expect From Bortezomib?

Culture-based analyses revealed that lacticin 3147 (50?��mol?l?1) significantly inhibited Streptococcus spp. present in human saliva (P? http://www.selleckchem.com/products/gsk1120212-jtp-74057.html results indicate that lacticin 3147 may be an effective therapy against Strep.?mutans and was shown to substantially attenuate its ability to form a biofilm. Significance and Impact of the Study:? Lacticin 3147 has the potential to be a useful adjunct to traditional oral therapeutic approaches in addition to its use as a bioactive ingredient for food applications. The oral cavity is home to a diverse microbial consortium comprised of more than 700 bacterial species (Hojo et?al. 2009). Residents of this community typically exist within dynamic biofilms on the surfaces of both hard and soft tissues. The biofilms associated with tooth surfaces (dental plaque) are highly organized structures that result from the sequential accumulation of a number of different micro-organisms (Marsh 2003a). Adhesion of bacteria present in saliva to the tooth surface and the colonization of attached cells are key steps in the developmental process of dental plaque. The subsequent accumulation of this plaque can give rise to two of the most common infectious diseases in humans: dental caries and/or periodontal disease (Jakubovics and Kolenbrander 2010). Oral streptococci are the major early colonizers of clean tooth enamel constituting 47�C82% of early plaque bacteria (Kolenbrander et?al. 1990). Indeed, Streptococcus is the only genus of http://www.selleck.cn/products/blu9931.html oral bacteria that exhibit both intra- and inter-generic co-aggregation and facilitate the adhesion and subsequent growth of streptococci, lactobacilli and potentially pathogenic Gram-negative bacterial species including Fusobacterium nucleatum and Porphyromonas gingivalis (Kolenbrander et?al. 2002). In the absence http://www.selleckchem.com/products/Bortezomib.html of oral streptococci and other early colonizers, both Fus. nucleatum and Porphyromonas gingivalis are rarely identified in appreciable numbers (Jenkinson and Lamont 2005). Historically, Streptococcus mutans has been considered the principal etiological agent of dental caries and, in the presence of dietary sugars, is a persistent colonizer of the tooth surface despite mechanical removal (He et?al. 2007). However, recent evidence suggests that dental caries and periodontal disease are largely polymicrobial and may arise as a result of environmental perturbations of the tooth habitat, the so-called ecological plaque hypothesis (Marsh 2003a). Consequently, novel therapeutic agents that are able to inhibit initial plaque formation may provide a useful adjunct to the treatment and prevention of oral infectious diseases, and in particular dental caries. Recently, a number of antimicrobial peptides (AMPs) have been examined to assess their activity against oral bacteria (Wei et?al. 2006; Beckloff et?al.